DPYSL5 and myasthenia gravis: We describe the case of a patient with recently diagnosed myasthenia gravis with thymoma, in whom SARS-CoV-2 infection triggered a paraneoplastic syndrome, through the generation of autoantibodies to 2 neurogenic epitopes, collapsin-response-mediator protein-5 (CRMP-5) and alpha-amino-3-hydroxyl-5methyl-4isoxazole propionic acid receptor (AMPAR).4